Behavior clinical trials

Explore recruiting behavior clinical trials.

Recruiting behavior studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Behavior trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Repurposing mirtazapine in Rett syndrome: a multicentric open label Phase II study (MirtaRett Study).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Neurodevelopmental outcome after standard dose sevoflurane versus low-dose sevoflurane/dexmedetomidine/remifentanil anaesthesia in young children

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

ALaDIN - Use of low doses of interleukin-2 in autism spectrum disorders

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, placebo-controlled trial to assess the efficacy, tolerability, and pharmacokinetics of clemastine in children and adults with Pitt-Hopkins syndrome

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms of Radiprodil in Patients with Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD) Type II.

Spain, Poland, Italy, Netherlands, Belgium

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Behavior trials by city

Behavior in Toronto Behavior in Vancouver Behavior in Montreal Behavior in Calgary Behavior in Edmonton Behavior in Ottawa Behavior in Winnipeg Behavior in Quebec City Behavior in Hamilton Behavior in Kitchener Behavior in London Behavior in Halifax Behavior in New York Behavior in Los Angeles Behavior in Chicago Behavior in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease